The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus

Julie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne Mahe, Philip Berardi, Mark D Minden, Joseph M Brandwein, Andre C Schuh · 2023

Read The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus by Julie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne Mahe, Philip Berardi, Mark D Minden, Joseph M Brandwein, Andre C Schuh (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10742150.txt.

Description

Julie Bergeron and others wrote Canadian consensus guidance on leukemia testing in 2023. One gene fault appears in many myeloid leukemia cases. That fault signals worse results for patients. Testing now shapes first treatment choices. Practice still varied across Canadian centres. A uniform approach was the goal.

Six care questions framed the joint guidance. Topics covered testing at first finding. Relapse testing was also covered. Leftover disease tracking raised further questions. Fault burden and write-ups were covered. Evidence and Canadian know-how were joined. Labs and clinics both get guidance. Steady care across regions should follow.

Catalog record

CREATORJulie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne Mahe, Philip Berardi, Mark D Minden, Joseph M Brandwein, Andre C Schuh
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE90 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10742150

Browse the full library · About the Tower of Babel